You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory glioma

Showing 1 - 25 of 9,780
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

High-Grade Glioma Trial in New York, Houston, Madison (CLR 131)

Not yet recruiting
  • High-Grade Glioma
  • CLR 131
  • New York, New York
  • +2 more
Nov 3, 2022

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)

Terminated
  • Brain and Central Nervous System Tumors
  • Chicago, Illinois
    Rush Cancer Institute at Rush University Medical Center
Jan 5, 2023

Recurrent Malignant Glioma Trial in Goyang-si (YYB-103)

Recruiting
  • Recurrent Malignant Glioma
  • Goyang-si, Gyeonggi, Korea, Republic of
    National Cancer Center, Korea
Sep 12, 2022

Pontine Glioma Trial in Phoenix, Grand Rapids (Vismodegib)

Terminated
Has Results
  • Pontine Glioma
  • Phoenix, Arizona
  • +1 more
Apr 20, 2022

Glioma, Solid Tumor Trial in Beijing (GNC-039)

Recruiting
  • Glioma
  • Solid Tumor
  • Beijing, Beijing, China
  • +5 more
Jan 12, 2023

Glioblastoma, Diffuse Intrinsic Pontine Glioma Trial in Japan (DSP-7888)

Completed
  • Glioblastoma
  • Diffuse Intrinsic Pontine Glioma
  • Nagoya, Aichi, Japan
  • +5 more
Apr 9, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

High Grade Glioma Trial (Berubicin Hydrochloride)

Not yet recruiting
  • High Grade Glioma
  • Berubicin Hydrochloride
  • (no location specified)
Jul 14, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))

Not yet recruiting
  • Brain Tumor, Pediatric
  • +6 more
  • GD2-CART01 (iC9-GD2-CAR T-cells)
  • (no location specified)
Mar 18, 2022

Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Glioma, Malignant
  • San Francisco, California
  • +7 more
Mar 1, 2022

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab

    Recruiting
    • Relapsed Solid Tumor
    • +5 more
    • cemiplimab (monotherapy)
    • +3 more
    • Los Angeles, California
    • +19 more
    Jan 27, 2022

    Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

    Terminated
    • Glioma
    • +23 more
    • Tucson, Arizona
    • +11 more
    Sep 30, 2022

    Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

    Active, not recruiting
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • +10 more
    • FACT Complex-targeting Curaxin CBL0137
    • Birmingham, Alabama
    • +19 more
    Jun 29, 2022

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023